$631 Million is the total value of Rhenman & Partners Asset Management AB's 104 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 13.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | Horizon Pharma Plc | $25,885,000 | +128.5% | 1,751,322 | +150.2% | 4.10% | +88.8% |
| ESPR | Buy | Esperion Therapeutics Inc | $19,186,000 | +457.2% | 543,347 | +97.6% | 3.04% | +360.3% |
| BIIB | Buy | Biogen Inc | $18,593,000 | +82.1% | 68,000 | +88.9% | 2.94% | +50.4% |
| GKOS | Buy | Glaukos Corp | $16,714,000 | +320.8% | 325,800 | +181.3% | 2.65% | +247.8% |
| AMGN | Buy | Amgen Inc | $16,407,000 | +72.6% | 100,000 | +53.8% | 2.60% | +42.6% |
| INCY | Sell | Incyte Corp Ltd | $15,372,000 | +9.5% | 115,000 | -17.9% | 2.43% | -9.6% |
| ABMD | Buy | Abiomed Inc | $14,654,000 | +26.6% | 117,048 | +14.0% | 2.32% | +4.6% |
| MDT | Sell | Medtronic Plc | $14,591,000 | -4.8% | 181,115 | -15.9% | 2.31% | -21.4% |
| REGN | Buy | Regeneron Pharmaceuticals Inc | $14,338,000 | +47.4% | 37,000 | +39.6% | 2.27% | +21.8% |
| LLY | Sell | Eli Lilly & Co | $14,299,000 | -9.6% | 170,000 | -20.9% | 2.26% | -25.3% |
| AGN | Sell | Allergan Plc | $14,096,000 | -11.7% | 59,000 | -22.4% | 2.23% | -27.1% |
| GILD | Sell | Gilead Sciences Inc | $14,054,000 | -24.5% | 206,916 | -20.4% | 2.23% | -37.6% |
| EXEL | Sell | Exelixis Inc | $13,652,000 | +10.3% | 630,000 | -24.1% | 2.16% | -8.9% |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $13,543,000 | +20.7% | 111,702 | +21.8% | 2.14% | -0.3% |
| ITCI | Buy | Intra-Cellular Therapies Inc | $11,630,000 | +165.8% | 715,664 | +146.8% | 1.84% | +119.5% |
| ELGX | Buy | Endologix Inc | $11,584,000 | +252.2% | 1,600,000 | +178.3% | 1.83% | +190.6% |
| CELG | Celgene Corp | $11,572,000 | +7.5% | 93,000 | 0.0% | 1.83% | -11.2% | |
| PFE | Buy | Pfizer Inc | $11,475,000 | +6.0% | 335,422 | +0.6% | 1.82% | -12.4% |
| NKTR | Buy | Nektar Therapeutics | $11,031,000 | +119.3% | 470,000 | +14.6% | 1.75% | +81.2% |
| BMRN | Buy | BioMarin Pharmaceutical Inc | $10,973,000 | +164.9% | 125,000 | +150.0% | 1.74% | +118.9% |
| BMY | Sell | Bristol Myers Squibb Co | $10,930,000 | -33.4% | 201,000 | -28.5% | 1.73% | -45.0% |
| UNH | Sell | United Health Group Inc | $10,661,000 | -11.2% | 65,000 | -13.4% | 1.69% | -26.7% |
| NVRO | Buy | Nevro Corp | $10,552,000 | +62.6% | 112,614 | +26.1% | 1.67% | +34.3% |
| VRTX | Buy | Vertex Pharmaceuticals Inc | $10,390,000 | +116.9% | 95,013 | +46.1% | 1.64% | +79.2% |
| CVS | Sell | CVS Health Corp | $10,205,000 | -7.6% | 130,000 | -7.1% | 1.62% | -23.7% |
| MRK | Buy | Merck & Co Inc | $10,166,000 | +146.7% | 160,000 | +128.6% | 1.61% | +103.8% |
| CI | Sell | Cigna Corp | $9,375,000 | +1.9% | 64,000 | -7.2% | 1.48% | -15.8% |
| HCA | HCA Holdings Inc | $9,318,000 | +20.2% | 104,707 | 0.0% | 1.48% | -0.7% | |
| JAZZ | Buy | Jazz Pharmaceuticals Plc | $8,754,000 | +57.7% | 60,320 | +18.5% | 1.39% | +30.3% |
| KITE | Buy | Kite Pharma Inc | $8,634,000 | +140.7% | 110,000 | +37.5% | 1.37% | +98.7% |
| ZBH | Sell | Zimmer Biomet Hgs Inc | $8,548,000 | +3.5% | 70,000 | -12.5% | 1.35% | -14.5% |
| ABBV | Buy | AbbVie Inc | $8,471,000 | +17.6% | 130,000 | +13.0% | 1.34% | -2.8% |
| ALKS | Buy | Alkermes Plc | $8,214,000 | +95.5% | 140,409 | +85.7% | 1.30% | +61.4% |
| SUPN | Sell | Supernus Pharmaceuticals Inc | $7,199,000 | +14.0% | 230,000 | -8.0% | 1.14% | -5.8% |
| ALNY | Sell | Alnylam Pharmaceuticals Inc | $6,663,000 | +31.8% | 130,000 | -3.7% | 1.06% | +8.9% |
| AET | Sell | Aetna Inc | $6,633,000 | -13.7% | 52,000 | -16.1% | 1.05% | -28.8% |
| HUM | Sell | Humana Inc | $6,596,000 | -19.2% | 32,000 | -20.0% | 1.04% | -33.2% |
| HOLX | Sell | Hologic Inc | $6,383,000 | -0.6% | 150,000 | -6.2% | 1.01% | -17.9% |
| ESRX | Sell | Express Scripts Hg Co | $6,327,000 | -17.1% | 96,000 | -13.5% | 1.00% | -31.6% |
| CNC | Sell | Centene Corp | $6,242,000 | -26.4% | 87,593 | -41.6% | 0.99% | -39.2% |
| XNCR | Buy | Xencor Inc | $6,219,000 | +5.0% | 260,000 | +15.6% | 0.98% | -13.2% |
| ANTM | Sell | Anthem Inc | $6,196,000 | -26.0% | 37,468 | -35.7% | 0.98% | -38.9% |
| TMO | Sell | Thermo Fisher Scientific Inc | $6,144,000 | -3.2% | 40,000 | -11.1% | 0.97% | -20.0% |
| CAH | Buy | Cardinal Health Inc | $6,116,000 | +30.7% | 75,000 | +15.4% | 0.97% | +8.0% |
| DVAX | Buy | Dynavax Technologies Corp | $5,859,000 | +205.8% | 984,696 | +103.0% | 0.93% | +152.9% |
| EW | Sell | Edwards Lifesciences Corp | $5,644,000 | -14.0% | 60,000 | -14.3% | 0.89% | -28.9% |
| ABC | Sell | AmerisourceBergen Corp | $5,576,000 | +4.9% | 63,000 | -7.4% | 0.88% | -13.3% |
| SAGE | New | Sage Therapeutics Inc | $5,164,000 | – | 72,659 | +100.0% | 0.82% | – |
| ABT | New | Abbott Laboratories | $5,107,000 | – | 115,000 | +100.0% | 0.81% | – |
| LBIO | Lion Biotechnologies Inc | $4,843,000 | +7.2% | 650,000 | 0.0% | 0.77% | -11.4% | |
| DXCM | Sell | Dexcom Inc | $4,821,000 | -4.8% | 56,900 | -32.9% | 0.76% | -21.4% |
| PTLA | Portola Pharmaceuticals Inc | $4,734,000 | +74.6% | 120,805 | 0.0% | 0.75% | +44.2% | |
| ENDP | Buy | Endo International Plc | $4,490,000 | -9.2% | 402,303 | +34.0% | 0.71% | -25.0% |
| RVNC | Revance Therapeutics Inc | $4,368,000 | +0.5% | 210,000 | 0.0% | 0.69% | -16.9% | |
| UHS | Buy | Universal Health Services Inc B | $4,356,000 | +36.5% | 35,000 | +16.7% | 0.69% | +12.7% |
| RIGL | Rigel Pharmaceuticals Inc | $4,243,000 | +39.1% | 1,282,000 | 0.0% | 0.67% | +14.9% | |
| NXTM | Sell | NxStage Medical Inc | $4,129,000 | -0.9% | 153,901 | -3.1% | 0.65% | -18.0% |
| OMCL | Sell | Omnicell Inc | $4,006,000 | -0.3% | 98,537 | -16.9% | 0.63% | -17.7% |
| AERI | Buy | Aerie Pharmaceuticals Inc | $3,855,000 | +190.9% | 85,000 | +142.9% | 0.61% | +140.2% |
| FGEN | Buy | FibroGen Inc | $3,805,000 | +70.9% | 154,341 | +48.4% | 0.60% | +41.2% |
| WBA | Buy | Walgreens Boots Alliance Inc | $3,737,000 | +80.6% | 45,000 | +80.0% | 0.59% | +49.1% |
| DVA | Buy | DaVita Inc | $3,738,000 | +29.4% | 55,000 | +22.2% | 0.59% | +6.9% |
| NBIX | Buy | Neurocrine Biosciences Inc | $3,681,000 | +137.8% | 85,000 | +112.5% | 0.58% | +96.3% |
| MYL | Buy | Mylan N.V. | $3,509,000 | +818.6% | 90,000 | +800.0% | 0.56% | +661.6% |
| ICPT | Buy | Intercept Pharmaceuticals Inc | $3,393,000 | +56.1% | 30,000 | +50.0% | 0.54% | +28.8% |
| MGNX | Buy | Macrogenics Inc | $3,255,000 | +2.7% | 175,000 | +12.9% | 0.52% | -15.2% |
| ARRY | Sell | Array BioPharma Inc | $3,129,000 | -35.3% | 350,000 | -36.4% | 0.50% | -46.5% |
| IMMU | New | Immunomedics Inc | $3,103,000 | – | 479,610 | +100.0% | 0.49% | – |
| LH | Sell | Laboratory Corp of America Hgs | $3,092,000 | -19.7% | 21,550 | -28.2% | 0.49% | -33.6% |
| ACAD | Buy | Acadia Pharmaceuticals Inc | $3,094,000 | +53.2% | 90,000 | +28.6% | 0.49% | +26.6% |
| ISRG | New | Intuitive Surgical Inc | $3,066,000 | – | 4,000 | +100.0% | 0.49% | – |
| RDUS | Buy | Radius Health Inc | $2,899,000 | +38.6% | 75,000 | +36.4% | 0.46% | +14.5% |
| TTPH | Tetraphase Pharmaceuticals Inc | $2,757,000 | +128.0% | 300,000 | 0.0% | 0.44% | +88.4% | |
| ADMS | Buy | Adamas Pharmaceuticals Inc | $2,713,000 | +23.5% | 155,000 | +19.2% | 0.43% | +2.1% |
| KERX | Keryx Biopharmaceuticals Inc | $2,619,000 | +5.1% | 425,111 | 0.0% | 0.42% | -13.2% | |
| CMRX | Chimerix Inc | $2,552,000 | +38.7% | 400,000 | 0.0% | 0.40% | +14.4% | |
| CHRS | Coherus BioSciences Inc | $2,355,000 | -24.9% | 111,357 | 0.0% | 0.37% | -37.9% | |
| HALO | Sell | Halozyme Therapeutics Inc | $2,203,000 | +23.9% | 170,000 | -5.6% | 0.35% | +2.3% |
| BIVV | New | Bioverativ Inc Reg S | $1,688,000 | – | 31,000 | +100.0% | 0.27% | – |
| PODD | Insulet Corp | $1,508,000 | +14.3% | 35,000 | 0.0% | 0.24% | -5.5% | |
| RGLS | Buy | Regulus Therapeutic Inc | $979,000 | -7.0% | 593,629 | +26.8% | 0.16% | -23.3% |
| BDX | Becton Dickinson & Co | $917,000 | +10.7% | 5,000 | 0.0% | 0.14% | -8.8% | |
| TSRO | Sell | Tesaro Inc | $769,000 | -71.4% | 5,000 | -75.0% | 0.12% | -76.4% |
| ACHN | Achillion Pharmaceuticals Inc | $699,000 | +1.9% | 166,000 | 0.0% | 0.11% | -15.9% | |
| CNCE | Concert Pharm Inc | $513,000 | +65.5% | 30,099 | 0.0% | 0.08% | +37.3% | |
| CATB | Buy | Catabasis Pharmaceuticals Inc | $497,000 | +37.7% | 310,756 | +210.8% | 0.08% | +14.5% |
| JPM | Buy | JPMorgan Chase & Co | $425,000 | +20.4% | 4,837 | +18.4% | 0.07% | -1.5% |
| ADVM | Adverum Biotechnologies Inc | $416,000 | -6.9% | 154,006 | 0.0% | 0.07% | -23.3% | |
| OREXQ | Orexigen Therapeutics Inc | $413,000 | +97.6% | 120,000 | 0.0% | 0.06% | +62.5% | |
| WFC | Buy | Wells Fargo & Co | $407,000 | +20.8% | 7,305 | +19.4% | 0.06% | -1.5% |
| XOM | Buy | Exxon Mobil Corp | $396,000 | +37.5% | 4,823 | +51.0% | 0.06% | +14.5% |
| HAL | Buy | Halliburton Co (Hg Co) | $380,000 | +42.3% | 7,718 | +56.5% | 0.06% | +17.6% |
| OCUL | Ocular Therapeutix Inc | $371,000 | +10.7% | 40,000 | 0.0% | 0.06% | -7.8% | |
| MSFT | Microsoft Corp | $316,000 | +6.0% | 4,793 | 0.0% | 0.05% | -12.3% | |
| QCOM | Buy | Qualcomm Inc | $308,000 | +14.5% | 5,368 | +30.1% | 0.05% | -5.8% |
| IBM | IBM Corp | $308,000 | +5.1% | 1,766 | 0.0% | 0.05% | -12.5% | |
| BUD | Buy | Anheuser-Busch InBev SA ADR spons repr 1 Share | $308,000 | +33.9% | 2,806 | +28.7% | 0.05% | +11.4% |
| TNDM | Tandem Diabetes Care Inc | $281,000 | -44.1% | 234,000 | 0.0% | 0.04% | -54.2% | |
| STAA | Staar Surgical Co | $281,000 | -9.9% | 28,711 | 0.0% | 0.04% | -26.7% | |
| MRTX | Mirati Therapeutics Inc | $260,000 | +9.2% | 50,000 | 0.0% | 0.04% | -10.9% | |
| F | Ford Motor Co | $262,000 | -4.0% | 22,511 | 0.0% | 0.04% | -21.2% | |
| THLD | Threshold Pharmaceuticals | $115,000 | +29.2% | 201,537 | 0.0% | 0.02% | +5.9% | |
| OPHT | Ophthotech Corp | $88,000 | -24.1% | 23,920 | 0.0% | 0.01% | -36.4% | |
| ANTH | Anthera Pharmaceuticals Inc | $85,000 | -34.6% | 200,000 | 0.0% | 0.01% | -48.0% | |
| CAT | Exit | Caterpillar Inc | $0 | – | -1,548 | -100.0% | -0.03% | – |
| MD | Exit | Mednax Inc | $0 | – | -9,000 | -100.0% | -0.12% | – |
| ILMN | Exit | Illumina Inc | $0 | – | -15,000 | -100.0% | -0.37% | – |
| PRGO | Exit | Perrigo Co Plc | $0 | – | -25,000 | -100.0% | -0.40% | – |
| Exit | NeuroDerm Ltd | $0 | – | -142,546 | -100.0% | -0.61% | – | |
| LIVN | Exit | Livanova Plc | $0 | – | -80,000 | -100.0% | -0.69% | – |
| ZLTQ | Exit | ZELTIQ Aesthetics Inc | $0 | – | -125,000 | -100.0% | -1.04% | – |
| ARIA | Exit | Ariad Pharmaceuticals Inc | $0 | – | -895,000 | -100.0% | -2.13% | – |
| TEVA | Exit | Teva Pharma Ind Ltd ADR repr 1 Share | $0 | – | -360,000 | -100.0% | -2.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-04-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.